Interestingly, in CAPS, in which increased secretion of IL-1β is due to a single nucleotide mutation in the NALP3 gene, controlling the caspase-1 activity, the main source of IL-1, are the mast cells [23]. This evidence concerns the gene CASP1 and cryopyrin-associated periodic syndrome.